ArticleTranslational lung cancer research2024

A non-interventional biomarker study in patients with adenocarcinoma of the lung treated with nintedanib plus docetaxel following progression on chemotherapy and/or immunotherapy: LUME-BioNIS.

Martin Reck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.